Literature DB >> 4487641

Geographical differences in antibiotic sensitivity patterns: comparison of susceptibility of staphylococci in Poland and Germany.

J Jeljaszewicz, G Pulverer.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4487641     DOI: 10.1007/bf02120553

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  9 in total

1.  THE CONSISTENCY OF IN VITRO MICROBIAL RESPONSE: A SURVEY OF THE AMERICAS, EUROPE AND JAPAN.

Authors:  H D ISENBERG
Journal:  Health Lab Sci       Date:  1965-07

2.  [Sensitivity of the Staphylococcus to the effect of bacitracin, soframycin, novobiocin, cycloserine, vancomycin, ristocetin and kanamycin].

Authors:  K WLODARCZAK; J JELJASZEWICZ
Journal:  Postepy Hig Med Dosw       Date:  1960 Jan-Feb       Impact factor: 0.270

3.  Phage typing of staphylococci.

Authors:  J E Blair; R E Williams
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

4.  [Current drug resistance of staphylococcus aureus].

Authors:  G Pulverer; G Damen
Journal:  Med Klin       Date:  1972-04-28

5.  Antibiotic resistance of Staphylococcus albus.

Authors:  G Pulverer; G Damen; M Neugebauer
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

6.  [Actual medical importance and antibiotic resistance of staphylococci].

Authors:  G Pulverer
Journal:  Dtsch Med Wochenschr       Date:  1972-02-18       Impact factor: 0.628

Review 7.  Antimicrobial therapy in medical gastrointestinal diseases.

Authors:  H D Riley
Journal:  Pediatr Clin North Am       Date:  1968-02       Impact factor: 3.278

8.  The resistance to antibiotics of strains of Staphylococcus aureus isolated in Poland.

Authors:  J Jeljaszewicz; J Hawiger
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

9.  Sensitivity of Staphylococcus aureus to 30 antibiotics.

Authors:  C Zak; J Hawiger; J Jeljaszewicz
Journal:  Chemotherapy       Date:  1969       Impact factor: 2.544

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.